[Medications when travelling with underlying inflammatory rheumatic disease]

Area of Science:

• Rheumatology
• Travel Medicine
• Pharmacology

Background:

• Traveling presents unique challenges for patients with rheumatic diseases.
• Managing medications, especially immunosuppressants and narcotics, requires specific considerations during travel.
• International regulations on controlled substances and varying healthcare standards necessitate advance planning.

Purpose of the Study:

• To provide comprehensive guidance for rheumatic disease patients on managing medications while traveling.
• To address logistical issues, including drug transportation, importation, and storage.
• To offer advice on managing immunosuppressive therapy, narcotics, and potential health risks like infections.

Main Methods:

• Review of current guidelines and best practices for medication management in travelers.
• Emphasis on collaboration between patients, physicians, and national agencies for necessary documentation.
• Consideration of factors like time zone changes, drug interactions, and individual medical needs.

Main Results:

• Recommendations for keeping medications in original packaging with inserts, stored in carry-on luggage.
• Highlighting the need for medical certificates for immunosuppressants and narcotics, potentially requiring agency certification.
• Stressing the importance of a personalized medical kit and awareness of circadian rhythm effects for glucocorticoid users.

Conclusions:

• Thorough planning and adherence to specific guidelines are crucial for rheumatic disease patients to travel safely.
• Patients must be aware of international regulations, necessary documentation, and potential health risks.
• Tailored medical kits and physician consultation are essential for optimizing health outcomes during travel.